Mohammed Ali Al Azem, MD | |
3747 Roswell Rd Ste 215, Marietta, GA 30062-6228 | |
(770) 422-1372 | |
Not Available |
Full Name | Mohammed Ali Al Azem |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 40 Years |
Location | 3747 Roswell Rd Ste 215, Marietta, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174612477 | NPI | - | NPPES |
000788444C | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 41254 (Georgia) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | 41254 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hamilton Medical Center | Dalton, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hamilton Physician Group, Inc | 4789708553 | 100 |
News Archive
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity and improve outcomes for many cancer patients, when compared to the adverse effects of standard chemotherapeutic drugs.
MIT researchers, working with scientists from Brigham and Women's Hospital, have developed a new way to power and communicate with devices implanted deep within the human body. Such devices could be used to deliver drugs, monitor conditions inside the body, or treat disease by stimulating the brain with electricity or light.
Breast cancer is the most commonly diagnosed cancer among American women and surgery is a primary treatment for these women. Among women receiving surgery, up to 13% will have a post-operative visit to an emergency department, according to recent research.
The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).
› Verified 4 days ago
Entity Name | Hamilton Physician Group, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235455569 PECOS PAC ID: 4789708553 Enrollment ID: O20100831000467 |
News Archive
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity and improve outcomes for many cancer patients, when compared to the adverse effects of standard chemotherapeutic drugs.
MIT researchers, working with scientists from Brigham and Women's Hospital, have developed a new way to power and communicate with devices implanted deep within the human body. Such devices could be used to deliver drugs, monitor conditions inside the body, or treat disease by stimulating the brain with electricity or light.
Breast cancer is the most commonly diagnosed cancer among American women and surgery is a primary treatment for these women. Among women receiving surgery, up to 13% will have a post-operative visit to an emergency department, according to recent research.
The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mohammed Ali Al Azem, MD Po Box 403631, Atlanta, GA 30384-3631 Ph: (770) 740-0895 | Mohammed Ali Al Azem, MD 3747 Roswell Rd Ste 215, Marietta, GA 30062-6228 Ph: (770) 422-1372 |
News Archive
The Canadian Medical Association (CMA), in partnership with the Canadian Association of Physician Assistants (CAPA) today launched the "Physician Assistant Toolkit", designed to enhance awareness and answer physician questions surrounding the role of physician assistants (PAs).
Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity and improve outcomes for many cancer patients, when compared to the adverse effects of standard chemotherapeutic drugs.
MIT researchers, working with scientists from Brigham and Women's Hospital, have developed a new way to power and communicate with devices implanted deep within the human body. Such devices could be used to deliver drugs, monitor conditions inside the body, or treat disease by stimulating the brain with electricity or light.
Breast cancer is the most commonly diagnosed cancer among American women and surgery is a primary treatment for these women. Among women receiving surgery, up to 13% will have a post-operative visit to an emergency department, according to recent research.
The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).
› Verified 4 days ago
Anu Kurl, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 400 Tower Rd Ne Ste 160, Marietta, GA 30060 Phone: 770-420-1690 Fax: 770-420-1661 | |
Dr. Sharon M Odell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 54 Tower Rd Ne, Marietta, GA 30060 Phone: 770-427-4682 Fax: 770-499-8562 | |
Dr. Helga Annalina Bahr, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 580 Atlanta Country Club Drive, Marietta, GA 30068 Phone: 770-988-8554 | |
Dr. Kaynessa Celena Providence, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 54 Tower Rd Ne, Marietta, GA 30060 Phone: 770-427-4682 Fax: 770-499-8562 | |
Dr. Ryan V Cantwell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 320 Kennestone Hospital Blvd, Suite 201, Marietta, GA 30060 Phone: 770-427-2457 Fax: 770-427-2706 | |
Dr. Joanne Zhiwen Zhu, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne # 111, Marietta, GA 30060 Phone: 770-793-7750 | |
Asif A Saberi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 55 Whitcher St Ne, Suite 160, Marietta, GA 30060 Phone: 770-422-1372 Fax: 770-423-9651 |